tempesttx.comBioTechFounded: 1900Funding to Date: $75.2MM
Tempest Therapeutics is a clinical-stage biotechnology company advancing small molecule therapeutics that modulate anti-tumor immunity pathways.
For more details on financing and valuation for Tempest Therapeutics, register or login.
Already registered? Click here to log in
To read this article and more news on Tempest Therapeutics, register or login.
Already registered? Click here to log in.
Forge and SharesPost have teamed up to provide you with an enhanced trading experience.